title: Rebound pustular psoriasis after brodalumab discontinuation.
authors.affiliation: Department of Dermatology, University Hospital of Nice, Rte de St-Antoine de Ginestiere, Nice, 06200, France.
authors.forename: A
authors.initials: A
authors.lastname: Khemis
authors.affiliation: Department of Dermatology, University Hospital of Nice, Rte de St-Antoine de Ginestiere, Nice, 06200, France.
authors.forename: M
authors.initials: M
authors.lastname: Cavalié
authors.affiliation: Department of Dermatology, University Hospital of Nice, Rte de St-Antoine de Ginestiere, Nice, 06200, France.
authors.forename: H
authors.initials: H
authors.lastname: Montaudié
authors.affiliation: Department of Dermatology, University Hospital of Nice, Rte de St-Antoine de Ginestiere, Nice, 06200, France.
authors.forename: J-P
authors.initials: JP
authors.lastname: Lacour
authors.affiliation: Department of Dermatology, University Hospital of Nice, Rte de St-Antoine de Ginestiere, Nice, 06200, France. passeron@unice.fr.|INSERM U1065, Team 12, C3M, Nice, France. passeron@unice.fr.
authors.forename: T
authors.initials: T
authors.lastname: Passeron
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D003879:Dermatologic Agents / Q000009:adverse effects*; D057915:Drug Substitution; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D012008:Recurrence
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C571216:brodalumab